Federico Mingozzi

Federico Mingozzi is the chief scientific officer at Spark Therapeutics, bringing two decades of experience in gene therapy, immunology, as well as biochemistry and molecular biology in both industry and academic settings. Federico began his scientific career studying the genetic basis of bleeding disorders.